These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30955140)

  • 1. Efficacy and Safety of Basal Analog Regimens in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Hong T; Lu J; Zhang P; Zhang Z; Xu Q; Li Y; Cui N; Grijalva A; Murray EM; Del Aguila MA; Bi Y
    Diabetes Ther; 2019 Jun; 10(3):1051-1066. PubMed ID: 30955140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.
    Wang C; Mamza J; Idris I
    Diabet Med; 2015 May; 32(5):585-94. PubMed ID: 25594251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis.
    Melo KFS; Bahia LR; Pasinato B; Porfirio GJM; Martimbianco AL; Riera R; Calliari LEP; Minicucci WJ; Turatti LAA; Pedrosa HC; Schaan BD
    Diabetol Metab Syndr; 2019; 11():2. PubMed ID: 30622653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Benefits and Harms of Basal Insulin Analogues for Type 2 Diabetes: A Systematic Review and Network Meta-analysis.
    Madenidou AV; Paschos P; Karagiannis T; Katsoula A; Athanasiadou E; Kitsios K; Bekiari E; Matthews DR; Tsapas A
    Ann Intern Med; 2018 Aug; 169(3):165-174. PubMed ID: 29987326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin glargine: a systematic review of a long-acting insulin analogue.
    Wang F; Carabino JM; Vergara CM
    Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar glucose control with basal-bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients with type 2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification.
    Malek R; Ajili F; Assaad-Khalil SH; Shinde A; Chen JW; Van den Berg E
    Diabetes Metab; 2015 Jun; 41(3):223-30. PubMed ID: 25483023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premixed vs basal-bolus insulin regimen in Type 2 diabetes: comparison of clinical outcomes from randomized controlled trials and real-world data.
    Anyanwagu U; Mamza J; Gordon J; Donnelly R; Idris I
    Diabet Med; 2017 Dec; 34(12):1728-1736. PubMed ID: 28945928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic insulin aspart 30: literature review of adverse events associated with treatment.
    Davidson J; Vexiau P; Cucinotta D; Vaz J; Kawamori R
    Clin Ther; 2005; 27 Suppl B():S75-88. PubMed ID: 16519039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of 50/50 Premixed Insulin Analogs in Type 2 Diabetes: Systematic Review and Clinical Recommendations.
    Deed G; Kilov G; Dunning T; Cutfield R; Overland J; Wu T
    Diabetes Ther; 2017 Dec; 8(6):1265-1296. PubMed ID: 29116584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis.
    Dawoud D; O'Mahony R; Wonderling D; Cobb J; Higgins B; Amiel SA
    Value Health; 2018 Feb; 21(2):176-184. PubMed ID: 29477399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control.
    Vos RC; van Avendonk MJ; Jansen H; Goudswaard AN; van den Donk M; Gorter K; Kerssen A; Rutten GE
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD006992. PubMed ID: 27640062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
    Lopez LM; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006133. PubMed ID: 22513937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
    Lopez LM; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31711271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
    Lopez LM; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006133. PubMed ID: 24788670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin therapy in type 2 diabetes: what is the evidence?
    van Avendonk MJ; Rutten GE
    Diabetes Obes Metab; 2009 May; 11(5):415-32. PubMed ID: 19175375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar glycaemic control with less nocturnal hypoglycaemia in a 38-week trial comparing the IDegAsp co-formulation with insulin glargine U100 and insulin aspart in basal insulin-treated subjects with type 2 diabetes mellitus.
    Philis-Tsimikas A; Astamirova K; Gupta Y; Haggag A; Roula D; Bak BA; Fita EG; Nielsen AM; Demir T
    Diabetes Res Clin Pract; 2019 Jan; 147():157-165. PubMed ID: 30448451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal-Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes.
    Linjawi S; Lee BW; Tabak Ö; Lövdahl S; Werther S; Abusnana S
    Diabetes Ther; 2018 Feb; 9(1):1-11. PubMed ID: 29129018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Basal insulin glargine using a basal-bolus regimen in a common clinical practice: observational, non-interventional, multicenter, national project LINDA (Lantus in daily practice - safety and efficacy in basal bolus regimen)].
    Zďarská DJ; Brož J; Křivská B; Rušavý Z; Kvapil M
    Vnitr Lek; 2014 Sep; 60(9):712-9. PubMed ID: 25294758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.